(29)Commission Implementing Regulation (EU) 2023/689note extended the approval period of the active substance fenpyroximate until 15 June 2026, and the approval periods of the active substances malathion and pyridaben until 31 July 2026.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.